151
Views
5
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE: CLINICAL TRANSLATIONAL THERAPEUTICS

Statins Use and Risk for Brain Metastasis From Lung Cancer

, , , &
Pages 68-72 | Published online: 27 Sep 2010

REFERENCES

  • Posner JB. Neurologic Complications of Cancer. Contemporary Neurology Series, vol. 45. Philadelphia, PA: Davis, 1995;3–14 and 77–110.
  • Walker AE, Robins M, Weinfeld FD. Epidemiology of brain tumors: the national survey of intracranial neoplasms. Neurology 1985;35:219–226.
  • Wingo PA, Tong T, Bolden S. Cancer statistics. CA Cancer J Clin 1995;45:8–30.
  • Patchell RA. The management of brain metastases. Cancer Treat Rev 2003;29:533–540.
  • Johnson JD, Young B. Demographics of brain metastasis. Neurosurg Clin N Am 1996;7:337–344.
  • Müller-Riemenschneider F, Bockelbrink A, Ernst I. Stereotactic radiosurgery for the treatment of brain metastases. Radiother Oncol 2009;91:67–74.
  • Kusama T, Mukai M, Iwasaki T. Inhibition of epidermal growth factor- induced RhoA translocation and invasion of human pancreatic cancer cells by 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors. Cancer Res 2001;61:4885–4891.
  • Nubel T, Dippold W, Kleinert H, Kaina B, Fritz G. Lovastatin inhibits Rho-regulated expression of E-selectin by TNFalpha and attenuates tumor cell adhesion. FASEB J 2004;18:140–142.
  • Wang IK, Lin-Shiau SY, Lin JK. Suppression of invasion and MMP-9 expression in NIH 3T3 and v-H-Ras 3T3 fibroblasts by lovastatin through inhibition of ras isoprenylation. Oncology 2000;59:245–254.
  • Feleszko W, Mlynarczuk I, Balkowiec-Iskra EZ. Lovastatin potentiates antitumor activity and attenuates cardiotoxicity of doxorubicin in three tumor models in mice. Clin Cancer Res 2000;6(5):2044–2052.
  • Littman ML, Taguchi T, Mosbach EH. Effect of cholesterol-free, fat-free diet and hypocholesteremic agents on growth of transplantable animal tumors. Cancer Chemother Rep 1996;50(1):25–45.
  • Schneider PD, Chan EK, Guzman IJ. Retarding Novikoff tumor growth by altering host rat cholesterol metabolism. Surgery 1980;87(4):409–416.
  • Mehta N, Hordines J, Sykes D, Doerr RJ, Cohen SA. Low density lipoproteins and Lovastatin modulate the organ-specific transendothelial migration of primary and metastatic human colon adenocarcinoma cell lines in vitro. Clin Exp Metastasis 1998;16:587–594.
  • Khurana V, Bejjanki HR, Caldito G, Owens MW. Statins reduce the risk of lung cancer in humans: a large case-control study of US veterans. Chest 2007;131(5):1282–1288.
  • Tanvetyanon T, Choudhury AM. Physician practice in the discontinuation of statins among patients with advanced lung cancer. J Palliat Care 2006;22(4):281–285.
  • Rosen S, Makuch R, Lichter A. Role of prophylactic cranial irradiation in prevention of CNS metastasis in SCLC. Am J Med 1983;74:615–623.
  • Sorensen JB, Hansen HH, Hansen M. Brain metastasis in adenocarcinoma of the lung: frequency, risk groups and prognosis. J Clin Oncol 1988;6:1474–1480.
  • Auperin A, Arriagada R, Pignon JP. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic cranial irradiation overview collaborative group. N Engl J Med 1999;341:476–484.
  • Gregor A, Cull A, Stephens RJ. Prophylactic cranial irradiation is indicated following complete response to induction therapy in small cell lung cancer: results of a multicentre randomised trial. United Kingdom Coordinating Committee for Cancer Research (UKCCCR) and the European Organization for Research and Treatment of Cancer (EORTC). Eur J Cancer 1997;33:1752–1758.
  • Corsini A, Bellosta S, Baetta R. New insights into the pharmacodynamic and pharmacokinetic properties of statins. Pharmacol Ther 1999;84:413–428.
  • Hosmer DW Jr., Lemeshow S. Applied Survival Analysis: Regression Modeling of Time to Event Data. New York, NY: John Wiley & Sons, 1999.
  • Riva M, Landonio G, Arena O, Citterio A, Galli C, Ferrante E, Brioschi A, Collice M, Gambacorta M, Scialfa G, Defanti CA, Siena S. Pathophysiology, clinical manifestations and supportive care of metastatic brain cancer. Forum (Genova) 2001;11(1):4–26.
  • Zimm S, Wampler GL, Stablein D, Hazra T, Young HF. Intracerebral metastases in solid-tumor patients: natural history and results of treatment. Cancer 1981;48:384–394.
  • Sundstrom JT, Minn H, Lertola KK, Nordmann E. Prognosis of patients treated for intracranial metastases with whole-brain irradiation. Ann Med 1998;30:296–299.
  • Nubel T, Dippold W, Kleinert H. Lovastatin inhibits Rho-regulated expression of E-selectin by TNFalpha and attenuates tumor cell adhesion. FASEB J 2004;18:140–142.
  • Wang IK, Lin-Shiau SY, Lin JK. Suppression of invasion and MMP-9 expression in NIH 3T3 and v-H-Ras 3T3 fibroblasts by lovastatin through inhibition of ras isoprenylation. Oncology 2000;59:245–254.
  • Kusama T, Mukai M, Iwasaki T. Inhibition of epidermal growth factor-induced RhoA translocation and invasion of human pancreatic cancer cells by 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors. Cancer Res 2001;61:4885–4891.
  • Mehta N, Hordines J, Sykes D. Low density lipoproteins and Lovastatin modulate the organ-specific transendothelial migration of primary and metastatic human colon adenocarcinoma cell lines in vitro. Clin Exp Metastasis 1998;16:587–594.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.